InvestorsHub Logo
Followers 73
Posts 5832
Boards Moderated 0
Alias Born 12/27/2005

Re: None

Saturday, 05/06/2023 11:20:38 AM

Saturday, May 06, 2023 11:20:38 AM

Post# of 20466
Pfizer chose what include in that article since they wrote it. Some have claimed the trial was meaningless, Pfizer doesn't even know about the trial or TolloVIR, etc. Seems they were 100% wrong.

The "Covid is Over" gang killed the funding opportunity for Phase III TolloVIR trial. You can't run one for free or $502

Why have antivirals when it's so easy to go to the hospital for a few weeks and suck O2?

Who cares that hospitalized Covid patients may end up with life long brain and organ damage? I've experience some of them first hand and their brain has been rattled from Covid as a number of studies have proven the impact of Covid.

For those that have fantastic insurance or already reached their high deductible, they can easily see 9 specialist after developing Long Covid. Maybe they can continue to see them for the rest of their lives?

This is a bad stock for traders. Traders should run far away. Stick with companies that have no products, services or revenue. Easier to manipulate the share price on those stocks.

When you hear about the upcoming TolloVid trial for Long Covid, please ignore.
Bullish
Bullish